Abstract:There is growing evidence that genetic diversity in Mycobacterium tuberculosis, the causative agent of tuberculosis, contributes to the outcomes of infection and public health interventions, such as vaccination. Epidemiological studies suggest that among the phylogeographic lineages of M. tuberculosis, strains belonging to a sublineage of Lineage 2 (mL2) are associated with concerning clinical features, including hypervirulence, treatment failure, and vaccine escape. The global expansion and increasing prevalence of this sublineage has been attributed to the selective advantage conferred by these characteristics, yet confounding host and environmental factors make it difficult to identify the bacterial determinants driving these associations in human studies. Here, we developed a molecular barcoding strategy to facilitate high-throughput, experimental phenotyping of M. tuberculosis clinical isolates. This approach allowed us to characterize growth dynamics for a panel of genetically diverse M. tuberculosis strains during infection and after vaccination in the mouse model. We found that mL2 strains exhibit distinct growth dynamics in vivo and are resistant to the immune protection conferred by Bacillus Calmette-Guerin (BCG) vaccination. The latter finding corroborates epidemiological observations and demonstrates that mycobacterial features contribute to vaccine efficacy. To investigate the genetic and biological basis of mL2 strains' distinctive phenotypes, we performed variant analysis, transcriptional studies, and genome-wide transposon sequencing. We identified functional genetic changes across multiple stress and host response pathways in a representative mL2 strain that are associated with variants in regulatory genes. These adaptive changes may underlie the distinct clinical characteristics and epidemiological success of this lineage. IMPORTANCE Tuberculosis, caused by the bacterium Mycobacterium tuberculosis, is a remarkably heterogeneous disease, a feature that complicates clinical care and public health interventions. The contributions of pathogen genetic diversity to this heterogeneity are uncertain, in part due to the challenges of experimentally manipulating M. tuberculosis, a slow-growing, biosafety level 3 organism. To overcome these challenges, we applied a molecular barcoding strategy to a panel of M. tuberculosis clinical isolates. This novel application of barcoding permitted the high-throughput characterization of M. tuberculosis strain growth dynamics and vaccine resistance in the mouse model of infection. Integrating these results with genomic analyses, we uncover bacterial pathways that contribute to infection outcomes, suggesting targets for improved therapeutics and vaccines.

High throughput analysis of phenotypic differences between H37Ra and H37Rv using Biolog Phenotype MicroArray

Genetic Basis of Virulence Attenuation Revealed by Comparative Genomic Analysis of Mycobacterium Tuberculosis Strain H37ra Versus H37rv

Mycobacterium Tuberculosis Short Mutant H37Rv-S with Reduced Growth Adaptability is More Readily Recognized by the Host Immune System

Comparative Analysis of Genomic Characteristics and Immune Response Between Mycobacterium Tuberculosis Strains Cultured Continuously for 25 Years and H37Rv.

The Bioinformatics Analysis Of Comparative Genomics Of Mycobacterium Tuberculosis Complex (Mtbc) Provides Insight Into Dissimilarities Between Intraspecific Groups Differingin Host Association, Virulence, And Epitope Diversity

Effect of Isoniazid Resistance on Pathogenicity of Mycobacterium tuberculosis Revealed by Oligonucleotide Microarray Profiling

Comparative transcriptomic analysis of THP‐1‐derived macrophages infected with Mycobacterium tuberculosis H37Rv, H37Ra and BCG

Untargeted Metabolomics Analysis Reveals Mycobacterium Tuberculosis Strain H37Rv Specifically Induces Tryptophan Metabolism in Human Macrophages

Comparative Proteomics Analysis of Human Macrophages Infected with Virulent Mycobacterium Bovis.

[Study on Mrna Differential Display in Mycobacterium Tuberculosis H37Rv and H37Ra].

Molecular Characterization of Clinical Isolates Ofmycobacterium Tuberculosisand Their Association with Phenotypic Virulence in Human Macrophages

Clinical Isolates of Mycobacterium Tuberculosis with Different Genotypes Exhibit Distinct Host Macrophage Responses in Vitro

Different Transcriptional Profiles of RAW264.7 Infected with Mycobacterium Tuberculosis H37Rv and BCG Identified Via Deep Sequencing.

Quantitative proteomics reveals that dormancy-related proteins mediate the attenuation in mycobacterium strains

Comparative Analysis on Proteomics Profiles of Intracellular and Extracellular M.tb and BCG from Infected Human Macrophages.

[Differential Expression of Apoptosis-Related Gene Induced by Clinical and Laboratory Mycobacterium Tuberculosis Strain in Macrophages U937 Revealed by Oligonucleotide Microarray].

[Comparison of the Promoter Activity of Metabolism-Related Pabb and Lpda Genes Between Mycobacterium Tuberculosis Strains H37Rv and H37Ra].

Comparative expression studies of a complex phenotype: cord formation in Mycobacterium tuberculosis.

Comprehensive Analysis of Protein Acetyltransferases of Human Pathogen Mycobacterium Tuberculosis

Comparative analysis of mycobacterium and related actinomycetes yields insight into the evolution of mycobacterium tuberculosis pathogenesis

Multiplexed Strain Phenotyping Defines Consequences of Genetic Diversity in Mycobacterium tuberculosis for Infection and Vaccination Outcomes